Cargando…
Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disorder and is associated with various metabolic diseases, including type 2 diabetes mellitus. There are no approved drugs for NAFLD, and the only approved treatment option is weight reduction. As insulin resistance plays an importan...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Association for the Study of the Liver
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641556/ https://www.ncbi.nlm.nih.gov/pubmed/32791578 http://dx.doi.org/10.3350/cmh.2020.0137 |